Loading company…
Massachusetts-based healthcare company developing CancerSEEK, a blood-based test for detecting multiple cancers early.
Thrive Earlier Detection Corp. develops CancerSEEK, a blood-based test that combines liquid biopsy technology with a machine learning engine to detect multiple types of cancer at an earlier stage. Established in 2019 and based in Massachusetts, US, the company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in